Legal & General Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.2M | Buy |
|
|||||
|
2025
Q2 | $14.4M | Buy |
|
|||||
|
2025
Q1 | $13.9M | Buy |
|
|||||
|
2024
Q4 | $7.19M | Buy |
|
|||||
|
2024
Q3 | $6.49M | Buy |
|
|||||
|
2024
Q2 | $4.73M | Sell |
|
|||||
|
2024
Q1 | $4.93M | Buy |
|
|||||
|
2023
Q4 | $4.84M | Sell |
|
|||||
|
2023
Q3 | $3.37M | Buy |
|
|||||
|
2023
Q2 | $3.78M | Buy |
|
|||||
|
2023
Q1 | $3.97M | Sell |
|
|||||
|
2022
Q4 | $4.46M | Buy |
|
|||||
|
2022
Q3 | $2.91M | Buy |
|
|||||
|
2022
Q2 | $265K | Buy |
|
|||||
|
2022
Q1 | $289K | Hold |
|
|||||
|
2021
Q4 | $236K | Hold |
|
|||||
|
2021
Q3 | $185K | Buy |
|
|||||
|
2021
Q2 | $88K | Sell |
|
|||||
|
2021
Q1 | $114K | Buy |
|
|||||
|
2020
Q4 | $46K | Hold |
|
|||||
|
2020
Q3 | $41K | Sell |
|
|||||
|
2020
Q2 | $84K | Buy |
|
|||||
|
2020
Q1 | $66K | Sell |
|
|||||
|
2019
Q4 | $81K | Sell |
|
|||||
|
2019
Q3 | $121K | Sell |
|
|||||
|
2019
Q2 | $93K | Buy |
|
|||||
|
2019
Q1 | $75K | Hold |
|
|||||
|
2018
Q4 | $28K | Hold |
|
|||||
|
2018
Q3 | $56K | Hold |
|
|||||
|
2018
Q2 | $46K | Sell |
|
|||||
|
2018
Q1 | $37K | Sell |
|
|||||
|
2017
Q4 | $68K | Buy |
|
|||||
|
2017
Q3 | $27K | Hold |
|
|||||
|
2017
Q2 | $29K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $12K | Hold |
|
|||||
|
2015
Q4 | $26K | Hold |
|
|||||
|
2015
Q3 | $31K | Buy |
|